{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:16:01Z","timestamp":1792016161038,"version":"4.4.0"},"reference-count":112,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T00:00:00Z","timestamp":1498003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T00:00:00Z","timestamp":1498003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress Anxiety"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1002\/da.22664","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T16:24:39Z","timestamp":1498062279000},"page":"1006-1017","source":"Crossref","is-referenced-by-count":90,"title":["Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?"],"prefix":"10.1155","volume":"34","author":[{"given":"Jasmine","family":"Turna","sequence":"first","affiliation":[{"name":"MacAnxiety Research Centre; McMaster University; Hamilton ON Canada"},{"name":"MiNDS Neuroscience Graduate Program; McMaster University; Hamilton ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Patterson","sequence":"additional","affiliation":[{"name":"MacAnxiety Research Centre; McMaster University; Hamilton ON Canada"},{"name":"Department of Psychiatry and Behavioural Neurosciences; McMaster University; Hamilton ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4357-5184","authenticated-orcid":false,"given":"Michael","family":"Van Ameringen","sequence":"additional","affiliation":[{"name":"MacAnxiety Research Centre; McMaster University; Hamilton ON Canada"},{"name":"Department of Psychiatry and Behavioural Neurosciences; McMaster University; Hamilton ON Canada"},{"name":"Hamilton Health Sciences; Hamilton ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,21]]},"reference":[{"issue":"4","key":"10.1002\/da.22664-BIB0001|da22664-cit-0001","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1176\/ajp.1974.131.4.448","article-title":"High frequency of dysphoric reactions to tetrahydrocannabinol among depressed patients","volume":"131","author":"Ablon","year":"1974","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/da.22664-BIB0002|da22664-cit-0002","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2125.1981.tb01294.x","article-title":"The seed and the soil: Effect of dosage, personality and starting state on the response to delta 9 tetrahydrocannabinol in man","volume":"12","author":"Ashton","year":"1981","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/da.22664-BIB0003|da22664-cit-0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.euroneuro.2010.06.007","article-title":"Genes differentially expressed in CB 1 knockout mice: Involvement in the depressive-like phenotype","volume":"21","author":"Aso","year":"2011","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/da.22664-BIB0004|da22664-cit-0004","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15622970802465807","article-title":"World federation of societies of biological psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders-First revision","volume":"9","author":"Bandelow","year":"2008","journal-title":"World Journal of Biological Psychiatry"},{"issue":"6","key":"10.1002\/da.22664-BIB0005|da22664-cit-0005","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/da.22664-BIB0006|da22664-cit-0006","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of \u0394-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.22664-BIB0007|da22664-cit-0007","volume-title":"Treating depression with cannabinoids (Cannabinoids 3)","author":"Blass","year":"2008"},{"key":"10.1002\/da.22664-BIB0008|da22664-cit-0008","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1002\/da.22664-BIB0009|da22664-cit-0009","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drugalcdep.2013.12.008","article-title":"Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD","volume":"136","author":"Bonn-Miller","year":"2014","journal-title":"Drug and alcohol Dependence"},{"issue":"1","key":"10.1002\/da.22664-BIB0010|da22664-cit-0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.addbeh.2006.03.018","article-title":"Marijuana use motives: Concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers","volume":"32","author":"Bonn-Miller","year":"2007","journal-title":"Addictive Behaviors"},{"issue":"12","key":"10.1002\/da.22664-BIB0011|da22664-cit-0011","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.euroneuro.2013.06.009","article-title":"The endocannabinoid system and emotional processing: A pharmacological fMRI study with\u2206 9-tetrahydrocannabinol","volume":"23","author":"Bossong","year":"2013","journal-title":"European Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/da.22664-BIB0012|da22664-cit-0012","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/JCP.0000000000000180","article-title":"Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: A retrospective evaluation","volume":"34","author":"Cameron","year":"2014","journal-title":"Journal of\u00a0Clinical Psychopharmacology"},{"issue":"12","key":"10.1002\/da.22664-BIB0013|da22664-cit-0013","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1073\/pnas.0900835106","article-title":"Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory","volume":"106","author":"Campolongo","year":"2009","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"10.1002\/da.22664-BIB0014|da22664-cit-0014","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: Involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behavioural Pharmacology"},{"key":"10.1002\/da.22664-BIB0015|da22664-cit-0015","unstructured":"Center for Behavioral Health Statistics and Quality 2015 Behavioral health trends in the United States: Results from the 2014 national survey on drug use and health (HHS publication no. SMA 15-4927, NSDUH series H-50) http:\/\/www.samhsa.gov\/data\/"},{"issue":"1-3","key":"10.1002\/da.22664-BIB0016|da22664-cit-0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2011.06.011","article-title":"Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence","volume":"120","author":"Cerd\u00e1","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/da.22664-BIB0017|da22664-cit-0017","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/00952991003713784","article-title":"Anxiety and mood disorders and cannabis use","volume":"36","author":"Cheung","year":"2010","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"3","key":"10.1002\/da.22664-BIB0018|da22664-cit-0018","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.npp.1300655","article-title":"Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear","volume":"30","author":"Chhatwal","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1002\/da.22664-BIB0019|da22664-cit-0019","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/npp.2013.97","article-title":"Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers","volume":"38","author":"Cooper","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/da.22664-BIB0020|da22664-cit-0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1037\/a0023076","article-title":"Posttraumatic stress disorder and cannabis use in a nationally representative sample","volume":"25","author":"Cougle","year":"2011","journal-title":"Psychology of Addictive Behaviors"},{"issue":"1","key":"10.1002\/da.22664-BIB0021|da22664-cit-0021","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1002\/da.22664-BIB0022|da22664-cit-0022","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1002\/da.22664-BIB0023|da22664-cit-0023","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: A critical review of the evidence","volume":"24","author":"Crippa","year":"2009","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"4","key":"10.1002\/da.22664-BIB0024|da22664-cit-0024","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00213-012-2955-y","article-title":"Cannabidiol enhances consolidation of explicit fear extinction in humans","volume":"226","author":"Das","year":"2013","journal-title":"Psychopharmacology"},{"issue":"9810","key":"10.1002\/da.22664-BIB0025|da22664-cit-0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/da.22664-BIB0026|da22664-cit-0026","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.aap.2012.07.016","article-title":"The effects of cannabis and alcohol on simulated driving: Influences of dose and experience","volume":"50","author":"Downey","year":"2013","journal-title":"Accident Analysis and Prevention"},{"key":"10.1002\/da.22664-BIB0027|da22664-cit-0027","unstructured":"D'Souza , D. C. 2016 Medical Cannabis: For which conditions and under what circumstances? Presented at the American Psychiatric Association Meeting, Atlanta, GA"},{"issue":"8","key":"10.1002\/da.22664-BIB0028|da22664-cit-0028","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"24","key":"10.1002\/da.22664-BIB0029|da22664-cit-0029","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1001\/jama.2015.6407","article-title":"Medical marijuana: Is the cart before the horse","volume":"313","author":"D'souza","year":"2015","journal-title":"JAMA"},{"issue":"S1","key":"10.1002\/da.22664-BIB0030|da22664-cit-0030","doi-asserted-by":"crossref","first-page":"377S","DOI":"10.1002\/j.1552-4604.1981.tb02617.x","article-title":"The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety","volume":"21","author":"Fabre","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/da.22664-BIB0031|da22664-cit-0031","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jad.2014.10.006","article-title":"The association between cannabis use and mood disorders: A longitudinal study","volume":"172","author":"Feingold","year":"2015","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/da.22664-BIB0032|da22664-cit-0032","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","article-title":"The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in post-traumatic stress disorder (PTSD)","volume":"15","author":"Fraser","year":"2009","journal-title":"CNS Neuroscience and Therapeutics"},{"key":"10.1002\/da.22664-BIB0033|da22664-cit-0033","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/S0924-9338(09)70439-0","article-title":"S39-01 Distinct effects of D9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"24","author":"Fusar-Poli","year":"2009","journal-title":"European Psychiatry"},{"issue":"4","key":"10.1002\/da.22664-BIB0034|da22664-cit-0034","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145709990617","article-title":"Modulation of effective connectivity during emotional processing by \u03949-tetrahydrocannabinol and cannabidiol","volume":"13","author":"Fusar-Poli","year":"2010","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/da.22664-BIB0035|da22664-cit-0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.smrv.2014.02.005","article-title":"The effects of cannabinoid administration on sleep: A systematic review of human studies","volume":"18","author":"Gates","year":"2014","journal-title":"Sleep Medicine Reviews"},{"key":"10.1002\/da.22664-BIB0036|da22664-cit-0036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jad.2014.09.016","article-title":"Cannabis use and mania symptoms: A systematic review and meta-analysis","volume":"171","author":"Gibbs","year":"2015","journal-title":"Journal of Affective Disorders"},{"issue":"S1","key":"10.1002\/da.22664-BIB0037|da22664-cit-0037","doi-asserted-by":"crossref","first-page":"383S","DOI":"10.1002\/j.1552-4604.1981.tb02618.x","article-title":"Single-dose study of nabilone in anxious volunteers","volume":"21","author":"Glass","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/da.22664-BIB0038|da22664-cit-0038","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pnpbp.2010.11.027","article-title":"Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice","volume":"35","author":"Gomes","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"7","key":"10.1002\/da.22664-BIB0039|da22664-cit-0039","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.pnpbp.2010.11.021","article-title":"Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants","volume":"35","author":"Gorzalka","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1002\/da.22664-BIB0040|da22664-cit-0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00213-011-2347-8","article-title":"Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: A pilot study","volume":"218","author":"Grant","year":"2011","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/da.22664-BIB0041|da22664-cit-0041","doi-asserted-by":"crossref","first-page":"509","DOI":"10.15288\/jsad.2016.77.509","article-title":"Associations of posttraumatic stress disorder symptoms with marijuana and synthetic cannabis use among young adult US Veterans: A pilot investigation","volume":"77","author":"Grant","year":"2016","journal-title":"Journal of Studies on\u00a0Alcohol and Drugs"},{"issue":"1","key":"10.1002\/da.22664-BIB0042|da22664-cit-0042","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/02791072.2013.873843","article-title":"PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program","volume":"46","author":"Greer","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"issue":"4","key":"10.1002\/da.22664-BIB0043|da22664-cit-0043","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clinical Pharmacokinetics"},{"issue":"2","key":"10.1002\/da.22664-BIB0044|da22664-cit-0044","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1522-7162(1996)4:2<77::AID-DEPR7>3.0.CO;2-C","article-title":"Do patients use marijuana as an antidepressant","volume":"4","author":"Gruber","year":"1996","journal-title":"Depression"},{"issue":"3","key":"10.1002\/da.22664-BIB0045|da22664-cit-0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/17523281.2012.659751","article-title":"Marijuana impacts mood in bipolar disorder: A pilot study","volume":"5","author":"Gruber","year":"2012","journal-title":"Mental Health and Substance Use"},{"issue":"7","key":"10.1002\/da.22664-BIB0046|da22664-cit-0046","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S2215-0366(15)00217-5","article-title":"Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: Results from annual, repeated cross-sectional surveys","volume":"2","author":"Hasin","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1002\/da.22664-BIB0047|da22664-cit-0047","unstructured":"Health Canada 2005 http:\/\/www.hc-sc.gc.ca\/dhp-mps\/prodpharma\/notices-avis\/conditions\/sativex_fs_fd_091289-eng.php"},{"key":"10.1002\/da.22664-BIB0111|da22664-cit-0111","unstructured":"Health Canada 2016 Consumer Information - Marijuana. Retrieved from https:\/\/www.canada.ca\/content\/dam\/hc-sc\/migration\/hc-sc\/dhp-mps\/alt_formats\/pdf\/marihuana\/info\/cons-eng.pdf"},{"issue":"4","key":"10.1002\/da.22664-BIB0048|da22664-cit-0048","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/026988119300700411","article-title":"Effective treatment of Tourette's syndrome with marijuana","volume":"7","author":"Hemming","year":"1993","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/da.22664-BIB0049|da22664-cit-0049","first-page":"103","article-title":"Cannabis use and expression of mania in the general population","volume":"95","author":"Henquet","year":"2006","journal-title":"Journal of Affective\u00a0Disorders"},{"issue":"12","key":"10.1002\/da.22664-BIB0050|da22664-cit-0050","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1073\/pnas.0901519106","article-title":"Endocannabinoids: The silent partner of glucocorticoids in the synapse","volume":"106","author":"Hill","year":"2009","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"10.1002\/da.22664-BIB0051|da22664-cit-0051","first-page":"943","article-title":"Nabilone, a cannabinol derivative, in the treatment of anxiety neurosis","volume":"29","author":"Ilaria","year":"1981","journal-title":"Current\u00a0Therapeutic Research,\u00a0Clinical\u00a0and Experimental"},{"issue":"1","key":"10.1002\/da.22664-BIB0052|da22664-cit-0052","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1185\/030079906X158066","article-title":"Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain","volume":"23","author":"Iskedjian","year":"2007","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/da.22664-BIB0053|da22664-cit-0053","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/da.22664-BIB0054|da22664-cit-0054","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jad.2015.10.048","article-title":"Mental health symptom severity in cannabis using and non-using Veterans with probable PTSD","volume":"190","author":"Johnson","year":"2016","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/da.22664-BIB0055|da22664-cit-0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","article-title":"Cannabidiol interferes with the effects of \u0394 9-tetrahydrocannabinol in man","volume":"28","author":"Karniol","year":"1974","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1002\/da.22664-BIB0056|da22664-cit-0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1002\/da.22664-BIB0057|da22664-cit-0057","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Archives of\u00a0General Psychiatry"},{"issue":"3","key":"10.1002\/da.22664-BIB0058|da22664-cit-0058","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1037\/adb0000110","article-title":"Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample","volume":"29","author":"Kevorkian","year":"2015","journal-title":"Psychology of addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors"},{"issue":"3","key":"10.1002\/da.22664-BIB0059|da22664-cit-0059","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archpsyc.1973.01750330041007","article-title":"\u03949-Tetrahydrocannabinol in depressed patients","volume":"28","author":"Kotin","year":"1973","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/da.22664-BIB0060|da22664-cit-0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-015-0657-y","article-title":"Cannabis and psychosis: A critical overview of the relationship","volume":"18","author":"Ksir","year":"2016","journal-title":"Current Psychiatry Reports"},{"issue":"9","key":"10.1002\/da.22664-BIB0061|da22664-cit-0061","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/0706743716659416","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 1. Disease burden and principles of care","volume":"61","author":"Lam","year":"2016","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/da.22664-BIB0062|da22664-cit-0062","first-page":"S200","article-title":"Anxiolytic effect of an oral cannabinoid in patients with anxiety","volume":"13","author":"Lee","year":"2009","journal-title":"European Journal of Pain"},{"key":"10.1002\/da.22664-BIB0063|da22664-cit-0063","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.addbeh.2016.05.015","article-title":"Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample","volume":"61","author":"Lin","year":"2016","journal-title":"Addictive Behaviors"},{"issue":"11","key":"10.1002\/da.22664-BIB0064|da22664-cit-0064","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/01.nmd.0000095123.68088.da","article-title":"Posttraumatic stress disorder and substance use in inner-city adolescent girls","volume":"191","author":"Lipschitz","year":"2003","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"5","key":"10.1002\/da.22664-BIB0065|da22664-cit-0065","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2354.2008.00917.x","article-title":"Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: Systematic review and meta-analysis","volume":"17","author":"Machado Rocha","year":"2008","journal-title":"European Journal of Cancer Care"},{"issue":"8","key":"10.1002\/da.22664-BIB0066|da22664-cit-0066","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1526-4637.2009.00703.x","article-title":"Systematic review and meta-analysis of cannabis treatment for chronic pain","volume":"10","author":"Mart\u00edn-S\u00e1nchez","year":"2009","journal-title":"Pain Medicine"},{"issue":"32","key":"10.1002\/da.22664-BIB0067|da22664-cit-0067","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Current Pharmaceutical Design"},{"issue":"8949","key":"10.1002\/da.22664-BIB0068|da22664-cit-0068","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(95)90485-9","article-title":"Nabilone in the treatment of multiple sclerosis","volume":"345","author":"Martyn","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/da.22664-BIB0069|da22664-cit-0069","volume-title":"Medical cannabis as treatment for chronic combat PTSD: Promising results in an open label pilot study","author":"Mashiah","year":"2012"},{"key":"10.1002\/da.22664-BIB0070|da22664-cit-0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annual Review of Psychology"},{"issue":"6","key":"10.1002\/da.22664-BIB0071|da22664-cit-0071","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1600-0447.1998.tb10127.x","article-title":"Cannabinoids: Possible role in patho-physiology and therapy of Gilles de la Tourette syndrome","volume":"98","author":"M\u00fcller-Vahl","year":"1998","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/da.22664-BIB0072|da22664-cit-0072","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette's syndrome with \u03949-tetrahydrocannabinol (THC): A randomized crossover trial","volume":"35","author":"M\u00fcller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1002\/da.22664-BIB0073|da22664-cit-0073","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/ajp.156.3.495","article-title":"Treatment of tourette's syndrome with delta-9-tetrahydrocannbinol","volume":"156","author":"Muller-Vahl","year":"1999","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/da.22664-BIB0074|da22664-cit-0074","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"\u03949-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: A 6-week randomized trial","volume":"64","author":"M\u00fcller-Vahl","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/da.22664-BIB0075|da22664-cit-0075","first-page":"289","volume-title":"The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"issue":"9","key":"10.1002\/da.22664-BIB0076|da22664-cit-0076","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/mp.2013.61","article-title":"Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study","volume":"18","author":"Neumeister","year":"2013","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1002\/da.22664-BIB0077|da22664-cit-0077","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1176\/appi.ajp.163.1.101","article-title":"Continuity of antidepressant treatment for adults with depression in the United States","volume":"163","author":"Olfson","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/da.22664-BIB0078|da22664-cit-0078","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacological Reviews"},{"issue":"7-8","key":"10.1002\/da.22664-BIB0079|da22664-cit-0079","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/dta.1377","article-title":"Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence","volume":"4","author":"Passie","year":"2012","journal-title":"Drug Testing and Analysis"},{"issue":"10","key":"10.1002\/da.22664-BIB0080|da22664-cit-0080","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.5603-07.2008","article-title":"Cannabinoid modulation of amygdala reactivity to social signals of threat in humans","volume":"28","author":"Phan","year":"2008","journal-title":"Journal of Neuroscience"},{"issue":"12","key":"10.1002\/da.22664-BIB0081|da22664-cit-0081","doi-asserted-by":"crossref","first-page":"e14433","DOI":"10.1371\/journal.pone.0014433","article-title":"Pharmacological treatment of painful HIV-associated sensory neuropathy: A systematic review and meta-analysis of randomised controlled trials","volume":"5","author":"Phillips","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1002\/da.22664-BIB0082|da22664-cit-0082","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.11.4.271","article-title":"Psychological effects in depressive patients of the marihuana homologue synhexyl","volume":"11","author":"Pond","year":"1948","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/da.22664-BIB0112|da22664-cit-0112","unstructured":"Public Health Agency of Canada 2012 A report on mental illnesses in Canada. Retrieved from http:\/\/www.phac-aspc.gc.ca\/publicat\/miic-mmac\/sum-eng.php"},{"key":"10.1002\/da.22664-BIB0083|da22664-cit-0083","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nlm.2013.09.009","article-title":"Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans","volume":"113","author":"Rabinak","year":"2014","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1002\/da.22664-BIB0084|da22664-cit-0084","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2012.06.063","article-title":"Cannabinoid facilitation of fear extinction memory recall in humans","volume":"64","author":"Rabinak","year":"2013","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1002\/da.22664-BIB0085|da22664-cit-0085","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.biopsych.2006.06.004","article-title":"Neurocircuitry models of posttraumatic stress disorder and extinction: Human neuroimaging research-past, present, and future","volume":"60","author":"Rauch","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1002\/da.22664-BIB0086|da22664-cit-0086","first-page":"763","volume-title":"The Pharmacology of Marihuana","author":"Regelson","year":"1976"},{"issue":"2","key":"10.1002\/da.22664-BIB0087|da22664-cit-0087","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/02791072.2011.587700","article-title":"Who are medical marijuana patients? Population characteristics from nine California assessment clinics","volume":"43","author":"Reinarman","year":"2011","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1002\/da.22664-BIB0088|da22664-cit-0088","unstructured":"Reznik , I. 2011 Medical cannabis use in post-traumatic stress disorder: A naturalistic observational study Abstract presented at the cannabinoid conference. Bonn, Germany 8 10"},{"issue":"8","key":"10.1002\/da.22664-BIB0089|da22664-cit-0089","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","article-title":"Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus","volume":"165","author":"Rock","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"8","key":"10.1002\/da.22664-BIB0090|da22664-cit-0090","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40261-014-0212-3","article-title":"Preliminary, open-label, pilot study of add-on oral \u03949-tetrahydrocannabinol in chronic post-traumatic stress disorder","volume":"34","author":"Roitman","year":"2014","journal-title":"Clinical Drug Investigation"},{"issue":"7","key":"10.1002\/da.22664-BIB0091|da22664-cit-0091","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/ajad.12270","article-title":"Are medical marijuana users different from recreational users? The view from primary care","volume":"24","author":"Roy-Byrne","year":"2015","journal-title":"American Journal on Addictions"},{"issue":"6","key":"10.1002\/da.22664-BIB0092|da22664-cit-0092","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00004714-198812000-00021","article-title":"Marijuana and Tourette's syndrome","volume":"8","author":"Sandyk","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/da.22664-BIB0093|da22664-cit-0093","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1176\/appi.ajp.2007.07061016","article-title":"Improvement in refractory obsessive compulsive disorder with dronabinol","volume":"165","author":"Schindler","year":"2008","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/da.22664-BIB0094|da22664-cit-0094","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0006-3223(86)90003-X","article-title":"Antianxiety effect of cannabis: Involvement of central benzodiazepine receptors","volume":"21","author":"Sethi","year":"1986","journal-title":"Biological Psychiatry"},{"issue":"4512","key":"10.1002\/da.22664-BIB0095|da22664-cit-0095","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/bmj.1.4512.918","article-title":"A new euphoriant for depressive mental states","volume":"1","author":"Stockings","year":"1947","journal-title":"British Medical Journal"},{"issue":"7","key":"10.1002\/da.22664-BIB0096|da22664-cit-0096","doi-asserted-by":"crossref","first-page":"e70052","DOI":"10.1371\/journal.pone.0070052","article-title":"Analysis of cannabis seizures in NSW, Australia: Cannabis potency and cannabinoid profile","volume":"8","author":"Swift","year":"2013","journal-title":"PloS one"},{"issue":"5","key":"10.1002\/da.22664-BIB0097|da22664-cit-0097","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1002\/da.22664-BIB0098|da22664-cit-0098","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuroscience.2011.09.031","article-title":"CB1 receptor-deficient mice as a model for depression","volume":"204","author":"Valverde","year":"2012","journal-title":"Neuroscience"},{"issue":"23","key":"10.1002\/da.22664-BIB0099|da22664-cit-0099","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/da.22664-BIB0100|da22664-cit-0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/0269215503cr581oa","article-title":"A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms","volume":"17","author":"Wade","year":"2003","journal-title":"Clinical Rehabilitation"},{"issue":"9","key":"10.1002\/da.22664-BIB0101|da22664-cit-0101","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.annepidem.2011.06.001","article-title":"Adolescent marijuana use from 2002 to 2008: Higher in states with medical marijuana laws, cause still unclear","volume":"21","author":"Wall","year":"2011","journal-title":"Annals of Epidemiology"},{"issue":"6","key":"10.1002\/da.22664-BIB0102|da22664-cit-0102","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.drugpo.2013.08.010","article-title":"Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use","volume":"24","author":"Walsh","year":"2013","journal-title":"International Journal of Drug Policy"},{"key":"10.1002\/da.22664-BIB0103|da22664-cit-0103","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cpr.2016.10.002","article-title":"Medical cannabis and mental health: A guided systematic review","volume":"51","author":"Walsh","year":"2017","journal-title":"Clinical Psychology Review"},{"issue":"9","key":"10.1002\/da.22664-BIB0104|da22664-cit-0104","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.4088\/JCP.14m09475","article-title":"Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder","volume":"76","author":"Wilkinson","year":"2015","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/da.22664-BIB0105|da22664-cit-0105","unstructured":"World Health Organization 2016 Management of Substance abuse: Cannabis http:\/\/www.who.int\/substance_abuse\/facts\/cannabis\/en\/"},{"issue":"4","key":"10.1002\/da.22664-BIB0106|da22664-cit-0106","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","article-title":"The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder","volume":"100","author":"Wu","year":"2012","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"3","key":"10.1002\/da.22664-BIB0113|da22664-cit-0113","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: From an inactive cannabinoid to a drug with wide spectrum of action","volume":"30","author":"Zuardi","year":"2008","journal-title":"Revista brasileira de psiquiatria"},{"issue":"1 Suppl","key":"10.1002\/da.22664-BIB0107|da22664-cit-0107","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1002\/da.22664-BIB0108|da22664-cit-0108","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/0269881108096521","article-title":"Cannabidiol was ineffective for manic episode of bipolar affective disorder","volume":"24","author":"Zuardi","year":"2010","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"10.1002\/da.22664-BIB0109|da22664-cit-0109","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by \u03949-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.22664","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/da.22664\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:04:49Z","timestamp":1671541489000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.22664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,21]]},"references-count":112,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"URL":"https:\/\/doi.org\/10.1002\/da.22664","archive":["Portico"],"relation":{},"ISSN":["1091-4269"],"issn-type":[{"value":"1091-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6,21]]}}}